"Effects of Exenatide on Kidney Function, Adverse Events, and Clinical End Points of Kidney Disease in Type 2 Diabetes" by Katherine R. Tuttle

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Follow Contact

Article

Effects of Exenatide on Kidney Function, Adverse Events, and Clinical End Points of Kidney Disease in Type 2 Diabetes

American Journal of Kidney Diseases (2013)

Katherine R. Tuttle, University of Washington
Cory Heilmann, Eli Lilly and Company
Byron J. Hoogwerf, Eli Lilly and Company
Carl Brown
Pamela W. Anderson, Eli Lilly and Company

Link

Disciplines

Medicine and Health Sciences and
Endocrinology, Diabetes, and Metabolism

Publication Date

January 8, 2013

DOI

10.1053/j.ajkd.2013.03.026

Citation Information

Katherine R. Tuttle, Cory Heilmann, Byron J. Hoogwerf, Carl Brown, et al.. "Effects of Exenatide on Kidney Function, Adverse Events, and Clinical End Points of Kidney Disease in Type 2 Diabetes" American Journal of Kidney Diseases Vol. 62 Iss. 2 (2013) p. 396 - 398
Available at: http://works.bepress.com/katherine-tuttle/93/